STOCK TITAN
  1. Home
  2. Sec-filings
  3. GILD
  4. [Form 4] Gilead Sciences Inc Insider Trading Activity

[Form 4] Gilead Sciences Inc Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GILD logo
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

#97 Ranked by Market Cap
#1386 Ranked by Dividends

GILD Latest News

Sep 25, 2025
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
Sep 22, 2025
Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline
Sep 4, 2025
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
Sep 4, 2025
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV
Sep 3, 2025
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

GILD Latest SEC Filings

Oct 6, 2025
[8-K] GILEAD SCIENCES, INC. Reports Material Event
Sep 30, 2025
[Form 4] GILEAD SCIENCES, INC. Insider Trading Activity
Sep 29, 2025
[144] GILEAD SCIENCES, INC. SEC Filing
Sep 15, 2025
[144] GILEAD SCIENCES, INC. SEC Filing
Sep 15, 2025
[144] GILEAD SCIENCES, INC. SEC Filing

GILD Stock Data

144.90B
1.24B
0.1%
90.75%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
FOSTER CITY